Thursday, September 3

2:30 – 3:30 pm

Precision Health Care: Pharmacogenetics and Next Generation Sequencing Through the Lens of Pediatric Oncology (216)

Newly diagnosed patients and their families are offered numerous genetic and genomic testing options including predictive and diagnostic screening. Screening provides guidance for inpatient care based on patient classification, medication management, disease susceptibility, and potential understanding of disease etiology.

Speaker:
Belinda Mandrell, PhD RN CPNP
CNE Hours
1
2:30 – 3:30 pm

Marijuana, Hemp, and the Child with Cancer (217)

Many pediatric oncology patients report medical marijuana (MMJ) and hemp-based CBD use. Over 4,000 children are registered users of marijuana in Colorado, the first state to legalize recreational marijuana. Eleven states and Washington, DC have legalized marijuana for recreational use for adults older than 21.

Speaker:
Molly Hemenway, DNP MS AC/PC-CPNP
CNE Hours
1
2:30 – 3:30 pm

Neurofibromatosis type 1 Diagnostic Updates and Plexiform Neurofibroma Treatment Options (218)

Neurofibromatosis (NF) 1 is a progressive autosomal dominant disorder that results from a germline mutation of a protein called neurofibromin that occurs in one out of every 3500 births (AANS, 2019). The clinical diagnosis of NF1 is based on the presence of two or more cardinal symptoms identified in the 1988 National Institute of Health (NIH) Diagnostic Criteria.

Speaker:
Racheal Bingham, MSN CPNP CPON®
CNE Hours
1
2:30 – 3:30 pm

Communication Pearls for Navigating Difficult Conversations (219)

Communication is the root of many conflicts in health care and the cause of up to 60% of all hospital adverse events according to the Joint Commission (Mueller et al, 2018). The nurse’s role is inherently different from the physician’s role in regard to delivering difficult news, but the nurse is often left to answer the questions that arise from these conversations.

Speaker:
Joy Hesselgrave, MSN RN CHPPN CPON®
Gina Santucci, FNP APRN-BC
CNE Hours
1